Saroja Pharma Industries India Share Price
Start SIP in Saroja Pharma Industries India
Start SIPSaroja Pharma Industries India Performance
Day Range
- Low 58
- High 60
52 Week Range
- Low 33
- High 83
- Open Price60
- Previous Close60
- Volume11200
Saroja Pharma Industries India Investment Rating
-
Master Rating:
-
Saroja Pharma Industries India Ltd has an operating revenue of Rs. 183.16 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 41 | 50 |
| Operating Expenses Annual Cr | 38 | 47 |
| Operating Profit Annual in Cr | 3 | 3 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 1 | 1 |
| Tax Annual Cr | 0 | 0 |
| Net Profit Annual Cr | 1 | 1 |
Saroja Pharma Industries India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 12
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹53.78
- 50 Day
- ₹49.07
- 100 Day
- ₹48.51
- 200 Day
- ₹
- 20 Day
- ₹52.14
- 50 Day
- ₹46.79
- 100 Day
- ₹44.70
- 200 Day
- ₹
Saroja Pharma Industries India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 59.40 |
| Second Resistance | 60.80 |
| Third Resistance | 61.60 |
| RSI | 60.56 |
| MFI | 80.72 |
| MACD Single Line | 3.39 |
| MACD | 4.33 |
| Support | |
|---|---|
| First Support | 57.20 |
| Second Support | 56.40 |
| Third Supoort | 55.00 |
Saroja Pharma Industries India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 11,200 | 1,120,000 | 100 |
| Week | 30,400 | 1,824,000 | 60 |
| 1 Month | 24,600 | 1,619,910 | 65.85 |
| 6 Month | 7,419 | 588,355 | 79.3 |
Saroja Pharma Industries India Result Highlights
Saroja Pharma Industries India Synopsis
NSE-Medical-Supplies
Saroja Pharma Indust belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 50.19 Cr. and Equity Capital is Rs. 2.94 Cr. for the Year ended 31/03/2023. Saroja Pharma Industries India Ltd. is a Public Limited Listed company incorporated on 14/01/2019 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24110MH2019PLC319508 and registration number is 319508.| Market Cap | 24 |
| Sales | 41 |
| Shares in Float | 0.11 |
| No of funds | |
| Yield |
| Book Value | 1.65 |
| U/D Vol ratio | 3.3 |
| LTDebt / Equity | 18 |
| Alpha | -0.06 |
| Beta | 0.66 |
Saroja Pharma Industries India Shareholding Pattern
| Owner Name | Mar-24 | Sep-23 |
|---|---|---|
| Promoters | 73.02% | 73.02% |
| Individual Investors | 24.08% | 24.32% |
| Others | 2.9% | 2.66% |
Saroja Pharma Industries India Management
| Name | Designation |
|---|---|
| Mr. Biju Gopinathan Nair | Chairman & Managing Director |
| Mr. Manish Dasharath Kamble | Whole Time Director |
| Mr. Pulinattu Nandakumar | Non Executive Director |
| Mr. Abhishek Agrawal | Independent Director |
| Ms. Pinky Kataruka | Independent Director |
| Ms. Sonal Jain | Independent Director |
Saroja Pharma Industries India Forecast
Price Estimates
Saroja Pharma Industries India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-29 | Audited Results |
Saroja Pharma Industries India FAQs
What is Share Price of Saroja Pharma Industries India ?
Saroja Pharma Industries India share price is ₹58 As on 11 September, 2024 | 22:44
What is the Market Cap of Saroja Pharma Industries India ?
The Market Cap of Saroja Pharma Industries India is ₹23.3 Cr As on 11 September, 2024 | 22:44
What is the P/E ratio of Saroja Pharma Industries India ?
The P/E ratio of Saroja Pharma Industries India is As on 11 September, 2024 | 22:44
What is the PB ratio of Saroja Pharma Industries India ?
The PB ratio of Saroja Pharma Industries India is 1.6 As on 11 September, 2024 | 22:44